Marx, Nikolaus <br/><br/>
Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products.  [electronic resource] 

 -  Diabetes  Oct 2004 
 - 2662-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0012-1797 
<br/><br/><label>Standard No.: </label>10.2337/diabetes.53.10.2662  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cells, Cultured<br/>Endothelium, Vascular--drug effects<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>NF-kappa B--metabolism<br/>Pioglitazone<br/>Promoter Regions, Genetic--drug effects<br/>RNA, Messenger--genetics<br/>Receptor for Advanced Glycation End Products<br/>Receptors, Immunologic--drug effects<br/>Rosiglitazone<br/>Thiazolidinediones--pharmacology<br/>Transcription, Genetic--drug effects<br/>Umbilical Veins